Columna Capital

📢 Columna Capital announces the successful final close of Fund III at €290m! We are delighted to announce our third and largest fund capital raise since the launch of our maiden fund in 2016, underscoring strong investor confidence and demand despite a challenging fundraising environment. We’re especially pleased that 75% of existing investors increased their commitment in Fund III, and to have attracted a number of high-calibre new investors from across the world. It’s testament to the strong track record and commitment of the Columna Capital team, and we’re looking forward to continuing our partnership with exceptional entrepreneurs and businesses on their growth journeys to come. Get more details below, and click the link in the comments for more 👇 #ColumnaCapital #PrivateEquity #FundClose

Our team had the privilege of attending the 10th Animal Health Innovation event in London—continuing a tradition we’ve maintained since 2018. The conference, which brought together leaders from both the pet and livestock sectors, provided us with valuable insights into the evolving landscape of animal health. Here are some key takeaways: 📈 Innovative technologies & AI: We saw first-hand how breakthrough advancements in therapeutics and diagnostics, powered by AI-driven insights, are pushing the boundaries of animal health. 🩺 Veterinary generics on the rise: In-depth discussions highlighted how vet generics are not only enhancing efficiencies but are also poised for significant growth, offering a contrast to challenges seen in human generics. 🤝 Collaboration is key: The event underscored the critical role of collaboration—both across industry sectors and with academic institutions—in accelerating innovation and opening new commercial opportunities.   These insights are particularly relevant for our portfolio companies in the space and we’re excited to support them as they continue to leverage learnings, driving forward-thinking solutions and continued growth in the #AnimalHealth industry. A heartfelt thank you to the organizers, speakers, and all the industry leaders who make this event so productive every year!   Santévet Clínicas MiVet Datamars Rory Devlin Charles Nantois   #AnimalHealthInnovation #VeterinaryMedicine 

💻 Excited to discuss how PE firms can effectively measure and manage their carbon footprint! Join a practical session on implementing carbon measurement across portfolio companies: 📅 20 February 2025 | ⏰ 15:00 CET Our ESG Manager, Sebastian Hanna will share real-world case studies and implementation strategies, while Andrés Cester CEO & Co-Founder of Manglai will provide expert insights into the evolving ESG landscape. Key topics include: ✅ The fundamentals of carbon measurement & its impact on investment value ✅ 2025 regulatory updates & what they mean for PE firms ✅ Step-by-step guidance for integrating carbon tracking across portfolios ✅ Lessons learned from Columna Capital’s ESG journey Save your spot at the link in comments.

Santévet takes another step in its ambition to democratize access to veterinary care by reinforcing its B2B offering, with the objective to achieve 25% of its new subscriptions through partners. Designed for banks, healthcare providers, e-commerce platforms, and specialised retailers, this new solution allows businesses to seamlessly incorporate pet insurance subscription into their services. 🚀 As veterinary costs continue to rise (+11%) and nearly half of European households (45%) include pets, the need for comprehensive pet health coverage is growing rapidly. Our B2B solution empowers businesses to meet this growing demand while creating added value for their customers. Early adopters like AXA Belgique, Allianz France, Japhy, Weenect etc have already partnered with Santévet, and more high-profile collaborations are on the horizon. To drive this inspiration, Santévet has appointed Antoine Lefranc as VP Commercial. With a proven track record in B2B growth, he brings valuable expertise to this exciting new chapter. 💡 Interested in learning more or joining the movement? Contact Antoine Lefranc directly or visit our website (link below). Together, let’s make pet healthcare more accessible for every pet owner across Europe. 🐕🐈🐇

🌟 Join Our Team! 🌟 We’re #hiring a French-speaking Private Equity Intern, to be based in our London office. If you’re passionate about building great businesses and believe you’d be a good fit for our dynamic team, Columna would love to hear from you. To apply, please email your CV and cover letter to info@columnacapital.com. We are accepting applications until February 16th.

MSA Mizar conclude il 2024 con una nuova operazione di M&A, che segna l'ingresso nel Gruppo di IMS, società francese attiva nel segmento della gestione dei sinistri in #outsourcing nei rami Motor e Property.    Con sede a Lille, IMS fornisce servizi di gestione dei sinistri, audit, sviluppo software e fatturazione centralizzata, avvalendosi di un team di 40 professionisti #specializzati. L'acquisizione consolida la presenza di MSA Mizar in Francia, dove è già presente con MSA Francia e getta le basi per una ulteriore crescita del business oltralpe. Per saperne di più, non perdere l'articolo su Milano Finanza. #outsourcing #claimsmanagement #press #media

We’ve officially launched our Milan office, marking a prominent milestone in Columna's expansion! 🔊 “We’re excited to take the next step in over a decade of history investing in Italy–establishing a strong, on-the-ground presence to support both Columna's existing portfolio companies and broader opportunities in the market,” said Andrea Frecchiami, Partner at Columna Capital. “With our dedicated team of Italian nationals, we’re in an ideal position to collaborate closely with current partners, engage with local investors, and pursue growth opportunities more effectively.” Our existing investments in Italy include: Over, a fast-growing provider of senior living solutions, healthcare platform BIANALISI SPA, a leader in the fragmented Italian market for clinical diagnostics, and MSA Mizar Group, a tech enabled full-service software provider of claims management services to the insurance industry. We’d also like to extend a special thank you to Stefania Peveraro and BeBeez Italia for helping to share our exciting news. Check out the highlights from our soft launch party in the video below! 🎥👇 Andrea Frecchiami Gemma Zaino Davide Gangemi Gabriele Mariani

We are delighted to announce Yan Sirera as CEO of Zumex Group. Yan brings over 25 years of global expertise in scaling businesses and delivering innovation within the consumer goods sector at the likes of Danone and PepsiCo, positioning Zumex for its next stage of international growth. In parallel, Víctor Bertolín, founder of Zumex, transitions to the role of Executive Chairman, ensuring the company’s founding vision and commitment to innovation remain central to its exciting future. 🍊 🍅 “Welcoming Yan to the Zumex family is an exciting moment for all of us,” said Bertolín. “His impressive track record and deep international experience combine perfectly to drive towards the future we envision for our company. I am confident that his leadership will guide us to even greater success.” With Yan’s leadership and Víctor’s oversight, supported by Columna's strategic partnership, Zumex is well-placed to solidify its position as a global leader in juicing solutions and pursue new opportunities in 2025 and beyond. Thanks to outlets like Expansión, Interempresas Media, S.L.U., Valencia Plaza, Revista Fruit Today magazine, Publicaciones Alimarket, S.A. and others for sharing this milestone announcement! #JuicingSolutions #LeadershipTransition #StrategicGrowth Michael Tose Jaime Bachs Lobo Thomas Mourry Carlos Alonso Calleja

🩺 Kicking off the week with some insightful highlights from our Managing Partner and Co-Founder, Rory Devlin, featured in Investors in Healthcare! Rory delves into our strategic focus on investing in European lower mid-market companies, scaling growth by backing trends like preventative care and the humanization of pets—all whilst working closely with management to build businesses with enduring value. 💭 He commented, 'We are ambitious. On quite a few occasions, we’ve been able to scale businesses by growing between three and four times from a revenue perspective.' Discover how Columna empowers ambitious teams and fosters sustainable success by reading the full interview. Link below! 🔗 ⤵️ A big thank you to Nick Herbert for the engaging conversation. #PrivateEquity #InvestorsInHealthcare #SustainableGrowth #EuropeanMarkets #PartnershipCapital MSA Mizar Physidia BIANALISI SPA Clínicas MiVet Santévet https://lnkd.in/epCWpaJi

We’re excited to share an update from Santévet: the launch of the Pet Tech Observatory—a groundbreaking initiative and the first of its kind in Europe. 💻 📊 This research platform, built by the dedicated team at Santévet, offers a centralized hub for uncovering essential insights into the fast-evolving #PetTech ecosystem. From investment trends and market dynamics to leading companies across various countries, it provides a comprehensive view of the industry. Check out the highlights in this video, dive into the full findings on #ThePetTechObservatory's website (link below), and don’t forget to subscribe to their newsletter. It’s an invaluable resource for anyone passionate about the future of a sector driven by one uniting factor: our love for pets! 🐾 #TechInnovation #PetIndustryInsights #FutureOfPetCare Hugues Salord Charles Nantois Delphine Goor Thomas Mourry Vilmos Pongracz